WADA defends salbutamol rules after criticism over Chris Froome case


Current regulations will not change unless their is a scientific basis for doing so, says anti-doping body

Chris Froome ahead of stage two of the 2018 Tour de France
WADA has launched a staunch defence of its regulations concerning the use of salbutamol after criticism in the wake of Chris Froome's salbutamol case.